Rituximab Used in Three Cases With Relapsed Non-Hodgkin’s Lymphoma

Molecular and Clinical Oncology - United Kingdom
doi 10.3892/mco.2013.88
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Non-Neoformans Cryptococcemia in a Patient With Hodgkin’s Lymphoma

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2018English

Pcn93 - Economic Modeling for the Us of Intravenous vs Subcutaneous Rituximab in Non-Hodgkin’s Lymphoma Treated With R-Chop

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

rhTPO Combined With Chemotherapy and G-CSF for Autologous Peripheral Blood Stem Cells in Patients With Refractory/Relapsed Non-Hodgkin’s Lymphoma

Cancer Management and Research
Oncology
2019English

Unexpected Echocardiographic Findings in Patients With Non-Hodgkin’s Lymphoma – Asymptomatic Myxoma

Cardiologia Croatica
Cardiovascular MedicineCardiology
2016English

Primary Non-Hodgkin’s Lymphoma of the Talus

Scientific Journal of the Foot & Ankle
2019English

Two Cases of Pneumocystis Jiroveci Pneumonia With Non-Hodgkin's Lymphoma After CHOP-Based Chemotherapy Containing Rituximab

Journal of clinical and experimental hematopathology : JCEH
Medicine
2010English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology
Hematology
2018English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology
MedicineHematology
2013English

The Treatment of Relapsed or Refractory Intermediate Grade Non-Hodgkin’s Lymphoma With Autologous Bone Marrow Transplantation Followed by Cyclosporine and Interferon

Bone Marrow Transplantation
TransplantationHematology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy